Document Detail


Acquired inflammatory demyelinating neuropathies.
MedLine Citation:
PMID:  11345010     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The acquired demyelinating neuropathies can be divided into those with an acute onset and course and those with a more chronic course. The acute neuropathies present as Guillain-Barré syndrome and include acute inflammatory demyelinating polyradiculoneuropathy (AIDP), Miller Fisher syndrome, acute motor axonal neuropathy (AMAN), acute motor and sensory axonal neuropathy (AMSAN), and acute pandysautonomia. The chronic neuropathies are collectively known as chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and include MADSAM (multifocal acquired demyelinating sensory and motor neuropathy, also know as Lewis-Sumner syndrome) and DADS (distal acquired demyelinating symmetric neuropathy) as variants. The clinical features, pathology, pathogenesis, diagnosis, treatment, rehabilitation, and prognosis of these neuropathies are discussed.
Authors:
E R Ensrud; L S Krivickas
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Physical medicine and rehabilitation clinics of North America     Volume:  12     ISSN:  1047-9651     ISO Abbreviation:  Phys Med Rehabil Clin N Am     Publication Date:  2001 May 
Date Detail:
Created Date:  2001-05-09     Completed Date:  2001-09-20     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9102787     Medline TA:  Phys Med Rehabil Clin N Am     Country:  United States    
Other Details:
Languages:  eng     Pagination:  321-34, ix     Citation Subset:  IM    
Affiliation:
Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Clinical Trials as Topic
Combined Modality Therapy
Electrophysiology
Guillain-Barre Syndrome / diagnosis*,  drug therapy,  rehabilitation*
Humans
Immunoglobulins, Intravenous / administration & dosage
Plasma Exchange / methods
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / diagnosis*,  drug therapy,  rehabilitation*
Prognosis
Chemical
Reg. No./Substance:
0/Immunoglobulins, Intravenous

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Diabetic neuropathies.
Next Document:  Motor neuron disease.